Back to the full story12 sources · Moderna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock soared.◆ Timeline
Moderna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock soared.
14 reports in the order each was filed. Tap any entry to open that report at its source.
- 01NBC Bay AreaAug 19, 7:00 AMMerck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
- 02STATAug 19, 10:45 AMSTAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
- 03NBC NewsAug 19, 1:15 PMMerck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
- 04TimeAug 19, 1:49 PMPromising Results for mRNA Cancer Vaccine from Moderna and Merck
- 05NBC NewsAug 19, 4:49 PMMerck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma
- 06Ars TechnicaAug 19, 4:53 PMMRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
- 07CBS News — TopAug 19, 4:54 PMModerna stock surges as melanoma vaccine trial shows "landmark moment
- 08FortuneAug 19, 5:47 PMModerna’s and Merck’s personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and…
- 09ABC7 Los AngelesAug 19, 7:11 PMPersonalized mRNA cancer vaccine shows promise in extending life span in melanoma trial
- 10NBC NewsAug 19, 7:22 PMMerck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
- 11The New York TimesAug 19, 7:38 PMModerna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
- 12MarketWatchAug 19, 8:20 PMModerna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock soared.
- 13CNBCAug 19, 8:34 PMCancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar
- 14Al JazeeraAug 19, 8:39 PMModerna, Merck unveil mRNA-based cancer vaccine that cuts spread